» Articles » PMID: 16616355

Cancer Risks for Mismatch Repair Gene Mutation Carriers: a Population-based Early Onset Case-family Study

Overview
Specialty Gastroenterology
Date 2006 Apr 18
PMID 16616355
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Cancer risks for mismatch repair gene mutation carriers have been derived almost exclusively using families ascertained owing to their strong cancer family history. These may be overestimates, due to analytic problems, and not generalizable. We estimated average cancer risks for mutations identified in population-based early onset colorectal cancer cases (probands) unselected for family history.

Methods: Data were cancer histories and mutation status (carrier, non-carrier, or unknown) of 17 mismatch repair gene mutation carrier probands with colorectal cancer diagnosed before age 45 (8 hMLH1, 4 hMSH2, 4 hMSH6, 1 hPMS2) and their first- and second-degree relatives. We used modified segregation analysis theory, adjusting for the family being ascertained through the proband being an early onset mutation carrier.

Results: Eleven carrier probands (64%) were from families meeting the Amsterdam II criteria for hereditary nonpolyposis colorectal cancer. The cumulative risk for colorectal cancer (95% confidence interval) to age 70 was 45% (29%-62%) for men and 38% (19%-51%) for women. Corresponding risks were 67% (47%-84%) and 72% (48%-85%) for any hereditary nonpolyposis colorectal cancer-related cancer. Compared with the general population, colorectal cancer incidence for men was approximately 180-fold higher before age 50, but about the same after age 50. For women, incidence was approximately 100-fold higher before age 50 and 7-fold higher thereafter.

Conclusions: For carriers of the mutations in the mismatch repair genes that cause early onset colorectal cancer, colorectal cancer increases rapidly until age 50, and the incidence decreases to general population levels at older ages.

Citing Articles

[Gender-specific differences in the development of colorectal cancer in Lynch syndrome patients-A systematic review].

Dohmen J, Sommer N, van Beekum K, Nattermann J, Engel C, Kalff J Chirurgie (Heidelb). 2024; 95(9):696-708.

PMID: 39145869 DOI: 10.1007/s00104-024-02159-x.


Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.

Dal Buono A, Puccini A, Franchellucci G, Airoldi M, Bartolini M, Bianchi P Cancers (Basel). 2024; 16(5).

PMID: 38473212 PMC: 10930657. DOI: 10.3390/cancers16050849.


Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer.

Capasso I, Santoro A, Cordisco E, Perrone E, Tronconi F, Catena U Cancers (Basel). 2023; 15(5).

PMID: 36900193 PMC: 10000861. DOI: 10.3390/cancers15051400.


Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients.

Hoedjes M, Vrieling A, de Brauwer L, Visser A, Gomez Garcia E, Hoogerbrugge N Fam Cancer. 2022; 22(2):155-166.

PMID: 36151358 PMC: 10020312. DOI: 10.1007/s10689-022-00315-y.


A validation of models for prediction of pathogenic variants in mismatch repair genes.

Shyr C, Blackford A, Huang T, Ke J, Ouardaoui N, Trippa L Genet Med. 2022; 24(10):2155-2166.

PMID: 35997715 PMC: 10312204. DOI: 10.1016/j.gim.2022.07.004.